Review
Accepted on 18 Feb 2026
Bispecific and Trispecific Antibodies in Atopic Dermatitis: A Review of the Emerging Clinical Pipeline
Frontiers in Drug Discovery
157 Publications
volumes
Volume 6 - 2026
Specialty Grand Challenge
Published on 16 Feb 2026
Revisiting the grand challenges: the road travelled and ahead at the frontiers of computer-aided drug design
Frontiers in Drug Discovery
doi 10.3389/fddsv.2026.1780834
- 256 views
Mini Review
Accepted on 12 Feb 2026
Metal-based compounds and Chagas Disease treatment: current knowledge and therapeutic perspectives
Frontiers in Drug Discovery
Mini Review
Published on 11 Feb 2026
Standardization of canine infections for the development of antileishmanial drugs
Frontiers in Drug Discovery
doi 10.3389/fddsv.2026.1754269
- 388 views
Brief Research Report
Published on 28 Jan 2026
Structure-based virtual screening for TRPM8 modulators
Frontiers in Drug Discovery
doi 10.3389/fddsv.2026.1770904
- 730 views
Volume 5 - 2025
Original Research
Published on 16 Jan 2026
Enhancing structure-based virtual screening of MDM2–p53 inhibitors: a benchmark of machine learning vs. traditional docking scoring functions
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1731262
- 1,488 views
Brief Research Report
Published on 05 Jan 2026
Dual RNA polymerase I inhibition with CX-5461 and BMH-21 synergizes in breast cancer by activating p53-dependent stress
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1677461
- 958 views
Specialty Grand Challenge
Published on 05 Jan 2026
Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1752852
- 1,313 views
Original Research
Accepted on 26 Dec 2025
Across pre-clinical and clinical platforms, approved and investigational psychiatric drugs share pathways and associate with similar molecular functions
Frontiers in Drug Discovery
- 661 views
Review
Published on 10 Dec 2025
Exploring deep learning approaches in anticancer drug design: a review of recent advances
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1713308
- 1,793 views
Original Research
Published on 10 Dec 2025
A network-based protocol to prioritize compounds for biological testing: discovery of Anti-Staphylococcus aureus cacalol derivatives
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1724392
- 1,066 views
Original Research
Accepted on 09 Dec 2025
Multivalent display of membrane proteins using HIV1-Gag VLPs
Frontiers in Drug Discovery
- 348 views
Study Protocol
Published on 09 Dec 2025
Integrated in vivo and in silico evaluation of antimalarial compounds from Vernonia ambigua leaves identified by GC-MS profiling
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1635697
- 970 views
Original Research
Published on 10 Nov 2025
Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1679626
- 1,735 views
- 3 citations
Original Research
Published on 17 Sep 2025
Influence of divalent metal ions on gelation of a short heterochiral peptide
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1673051
- 1,432 views
Original Research
Published on 10 Sep 2025
Bioinformatics-driven identification and prioritization of PTSD targets based on published multi-omic data
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1613261
- 2,097 views
Perspective
Published on 03 Sep 2025
Advancing histone deacetylase 6 (HDAC6) as a promising therapeutic target for Alzheimer’s disease: from molecular insights to clinical prospects
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1662691
- 4,357 views
- 1 citation
Opinion
Published on 25 Aug 2025
On the biologically relevant chemical space: BioReCS
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1674289
- 3,802 views
- 3 citations
Mini Review
Published on 26 Jun 2025
AI-driven innovation in antibody-drug conjugate design
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1628789
- 11,122 views
- 10 citations
Editorial
Published on 10 Jun 2025
Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1636070
- 2,232 views
- 1 citation
Original Research
Published on 06 Jun 2025
Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1584801
- 2,459 views
Editorial
Published on 04 Jun 2025
Editorial: Enhancing drug discovery through structure-based design and computational techniques
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1632015
- 2,380 views
Original Research
Published on 30 May 2025
Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1591991
- 1,981 views
Original Research
Published on 15 Apr 2025
Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1525533
- 3,590 views
- 10 citations